Removal of pattern-breaking sequences in microtubule binding repeats produces instantaneous tau aggregation and

Asparouh Iliev Iliev1, Sundar Ganesan, Gertrude Bunt

  • 1Cell Biophysics Group, European Neuroscience Institute-Göttingen, Waldweg 33, 37073 Göttingen, Germany. ailiev@gwdg.de

Insights

Researchers created a novel tau protein mutant that rapidly aggregates and causes cell toxicity, mimicking Alzheimer's disease pathology. This offers a new tool to study tauopathies and identify therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Aggregated and phosphorylated tau protein is a key marker in Alzheimer's disease (AD) and tauopathies.
  • Understanding tau aggregation mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To engineer a tau mutant that rapidly aggregates and exhibits cytotoxicity.
  • To establish a new platform for studying the molecular basis of tau-related neurodegeneration.

Main Methods:

  • Identification of specific amino acid motifs within tau's microtubule-binding repeats.
  • Minimal mutations were introduced into identified 'breaking sequences' of tau.
  • Cellular assays were performed to assess aggregation, cytotoxicity, and phosphoepitope formation.

Main Results:

  • A novel tau mutant was generated with enhanced polar/apolar amino acid stretches, leading to rapid aggregation.
  • The mutant tau exhibited significant cytotoxicity and formed pathological phosphoepitopes (AT8, AT180, etc.) and conformational epitopes (MC-1, Alz50).
  • Toxicity was observed early, independent of extensive fibril formation, similar to pretangle tau pathology.

Conclusions:

  • Engineered tau mutants provide a valuable model for investigating the early mechanisms of tau toxicity in neurodegenerative diseases.
  • This research facilitates the study of pathologically aggregated tau and the identification of potential therapeutic targets.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...